Rudresh A H, Asati Vikas, Lakshmaiah K C, Lokanatha D, Babu Suresh, Rajeev L K, Lokesh K N, Babu Govind
Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bengaluru, Karnataka, India.
J Cancer Res Ther. 2019 Mar;15(Supplement):S56-S59. doi: 10.4103/0973-1482.204881.
Renal function assessment is of paramount importance before using the platinum agents especially cisplatin. Glomerular filtration rate (GFR) estimation by diethyl-triamine-penta-acetic acid (DTPA) scan (measured GFR [mGFR]) is considered gold standard.
The aim of this study is to know if we can replace the mGFR with the GFR estimation with Cockcroft-Gault formula (eGFR) in patients undergoing chemoradiation.
This is a prospective, descriptive study.
Patients who are planned for definitive chemoradiation will be eligible for the study. Renal function will be measured DTPA scan and Cockcroft-Gault (CG) formula. Subgroup analysis based on the weight, age, and sex will be done.
Demographic and renal function parameters were analyzed using summary measures. To test the significance of the difference between mGFR and cGFR, a paired t-test will be used; to look for an association between various estimates of renal function, the Pearson's correlation coefficient will be calculated using a two-tailed test.
Median mGFR of patients was 82.7 (range: 65-125 ml/min, standard deviation [SD] =14.0 ml/min) while the median eGFR as per the CG formula was 83.9 ml/min (range: 37-137 ml/min, SD = 24.4 ml/min). The median mGFR was only 1.2 ml/min lesser when measures by the CG formula with no significance difference between them (P = 0.66, 95% confidence interval: -4.5-6.3).
We concluded that in resource-limited setting eGFR using CG formula can replace mGFR, especially in patients with age <60 years. Although weight did not showed a significant difference by two methods, a study with large sample is needed to confirm the result.
在使用铂类药物尤其是顺铂之前,肾功能评估至关重要。通过二乙三胺五乙酸(DTPA)扫描估算的肾小球滤过率(GFR)(实测GFR [mGFR])被视为金标准。
本研究的目的是了解在接受放化疗的患者中,能否用Cockcroft - Gault公式估算的GFR(eGFR)替代mGFR。
这是一项前瞻性描述性研究。
计划接受根治性放化疗的患者符合本研究条件。将通过DTPA扫描和Cockcroft - Gault(CG)公式测量肾功能。将根据体重、年龄和性别进行亚组分析。
使用汇总指标分析人口统计学和肾功能参数。为检验mGFR和cGFR之间差异的显著性,将使用配对t检验;为寻找肾功能各种估算值之间的关联,将使用双尾检验计算Pearson相关系数。
患者的中位mGFR为82.7(范围:65 - 125 ml/分钟,标准差[SD] = 14.0 ml/分钟),而根据CG公式计算的中位eGFR为83.9 ml/分钟(范围:37 - 137 ml/分钟,SD = 24.4 ml/分钟)。用CG公式测量时,中位mGFR仅低1.2 ml/分钟,两者之间无显著差异(P = 0.66,95%置信区间:-4.5 - 6.3)。
我们得出结论,在资源有限的情况下,使用CG公式的eGFR可以替代mGFR,尤其是在年龄<60岁的患者中。虽然两种方法在体重方面未显示出显著差异,但需要进行大样本研究来证实该结果。